Management of atypical cranial meningiomas, Part 1: Predictors of recurrence and the role of adjuvant radiation after gross total resection

Neurosurgery

Volumn 75, Issue 4, 2014, Pages 347-354

  Sun, Sam Q ^a   Kim, Albert H ^b   Cai, Chunyu ^b   Murphy, Rory K J ^b   DeWees, Todd ^a   Sylvester, Peter ^a   Dacey, Ralph G ^b   Grubb, Robert L ^b   Rich, Keith M ^b   Zipfel, Gregory J ^b   Dowling, Joshua L ^b   Leuthardt, Eric C ^b   Leonard, Jeffrey R ^b   Evans, John ^b   Simpson, Joseph R ^a   Robinson, Clifford G ^a   Perrin, Richard J ^b   Huang, Jiayi ^a   Chicoine, Michael R ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Adjuvant; Local therapy; Meningioma mortality; Meningioma pathology; Meningioma therapy; Neoplasm recurrence; Prognosis; Radiotherapy; Retrospective studies

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ATYPICAL MENINGIOMA; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CEREBROVASCULAR ACCIDENT; CHILD; CLINICAL DECISION MAKING; CLINICAL FEATURE; COHORT ANALYSIS; CYTOREDUCTIVE SURGERY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; MIDDLE CEREBRAL ARTERY; MITOSIS INDEX; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; POSTERIOR FOSSA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION NECROSIS; RECURRENCE RISK; RETROSPECTIVE STUDY; SKULL BASE; STEREOTACTIC RADIOSURGERY; TUMOR INVASION; TUMOR RECURRENCE; ADJUVANT THERAPY; BRAIN NEOPLASMS; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; MENINGEAL NEOPLASMS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; RADIOTHERAPY; TREATMENT OUTCOME;

ADULT; AGED; BRAIN NEOPLASMS; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84923911736     PISSN: 0148396X     EISSN: 15244040     Source Type: Journal    
DOI: 10.1227/neu.0000000000000461     Document Type: Article

References (44)

1. Kleihues P, Cavenee WK. Pathology and Genetics of Tumours of the Nervous System. Lyon, France: International Agency for Research on Cancer; 2000.
2. Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol. 2012;14(suppl 5):v1-v49.
3. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2): 97-109.
4. Goyal LK, Suh JH, Mohan DS, Prayson RA, Lee J, Barnett GH. Local control and overall survival in atypical meningioma: A retrospective study. Int J Radiat Oncol Biol Phys. 2000;46(1):57-61.
5. Perry A. Unmasking the secrets of meningioma: A slow but rewarding journey. Surg Neurol. 2004;61(2):171-173.
6. Willis J, Smith C, Ironside J, Erridge S, Whittle I, Everington D. The accuracy of meningioma grading: A 10-year retrospective audit. Neuropathol Appl Neurobiol. 2005;31(2):141-149.
7. Modha A, Gutin PH. Diagnosis and treatment of atypical and anaplastic meningiomas: A review. Neurosurgery. 2005;57(3):538-550.
8. Palma L, Celli P, Franco C, Cervoni L, Cantore G. Long-term prognosis for atypical and malignant meningiomas: A study of 71 surgical cases. J Neurosurg. 1997;86(5):793-800.
9. Mawrin C, Perry A. Pathological classification and molecular genetics of meningiomas. J Neuro Oncol. 2010;99(3):379-391.
10. Pearson BE, Markert JM, Fisher WS, et al. Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria. Neurosurg Focus. 2008:24;E3.
11. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM.Meningioma grading: An analysis of histologic parameters. Am J Surg Pathol. 1997;21(12):1455-1465.
12. Lusis EA, Watson MA, Chicoine MR, et al. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Res. 2005;65(16):7121-7126.
13. Watson MA, Gutmann DH, Peterson K, et al. Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays. Am J Pathol. 2002;161(2):665-672.
14. Lin CK, Tsai WC, Lin YC, Hueng DY. Osteopontin predicts the behaviour of atypical meningioma. Histopathology. 2012;60(2):320-325.
15. Smith JS, Lal A, Harmon-Smith M, Bollen AW, McDermott MW. Association between absence of epidermal growth factor receptor immunoreactivity and poor prognosis in patients with atypicalmeningioma. J Neurosurg. 2007;106(6):1034-1040.
16. Gabeau-Lacet D, Aghi M, Betensky RA, Barker FG, Loeffler JS, Louis DN. Bone involvement predicts poor outcome in atypical meningioma. J Neurosurg. 2009; 111(3):464.
17. Aghi MK, Carter BS, Cosgrove GR, et al. Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery. 2009;64(1):56-60.
18. Park HJ, Kang H-C, Kim IH, et al. The role of adjuvant radiotherapy in atypical meningioma. J Neurooncol. 2013;115:241-247.
19. Stessin AM, Schwartz A, Judanin G, et al. Does adjuvant external-beam radiotherapy improve outcomes for nonbenign meningiomas? A Surveillance, Epidemiology, and End Results (SEER)-based analysis: clinical article. J Neurosurg. 2012;117(4):669-675.
20. Mair R, Morris K, Scott I, Carroll TA. Radiotherapy for atypical meningiomas: clinical article. J Neurosurg. 2011;115(4):811-819.
21. Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957;20(1):22-39.
22. Turkbey B, Mani H, Aras O, et al. Correlation of magnetic resonance imaging tumor volume with histopathology. J Urology. 2012;188(4):1157-1163.
23. Hakyemez B, Yildirim N, ErdoÄeYan C, Kocaeli H, Korfali E, Parlak M. Meningiomas with conventional MRI findings resembling intraaxial tumors: can perfusion-weighted MRI be helpful in differentiation? Neuroradiology. 2006;48(10): 695-702.
24. Rath P, Miller DC, Litofsky NS, et al. Isolation and characterization of a population of stem-like progenitor cells from an atypical meningioma. Exp Mol Pathol. 2011;90(2):179-188.
25. Chiu S-H, Wang I-D, Sytwu H-K, Hueng D-Y. Letter to the Editor: Atypical meningioma. J Neurosurg. 2013;118(4):912-913.
26. Kumar PP, Good RR, Skultety FM, Leibrock LG, Severson GS. Radiationinduced neoplasms of the brain. Cancer. 1987;59(7):1274-1282.
27. Crossen JR, Garwood D, Glatstein E, Neuwelt EA. Neurobehavioral sequelae of cranial irradiation in adults: A review of radiation-induced encephalopathy. J Clin Oncol. 1994;12(3):627-642.
28. Al-Mefty O, Topsakal C, Pravdenkova S, Sawyer JR, Harrison MJ. Radiationinduced meningiomas: clinical, pathological, cytokinetic, and cytogenetic characteristics. J Neurosurg. 2004;100(6):1002-1013.
29. Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol. 2004;5(7):399-408.
30. Al-Mefty O, Kersh JE, Routh A, Smith RR. The long-term side effects of radiation therapy for benign brain tumors in adults. J Neurosurg. 1990;73(4):502-512.
31. Lee KD, DePowell JJ, Air EL, Dwivedi AK, Kendler A, McPherson CM. Atypical meningiomas: is postoperative radiotherapy indicated? Neurosurg Focus. 2013;35(6):E15.
32. Hardesty DA, Wolf AB, Brachman DG, et al. The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection: clinical article. J Neurosurg. 2013;119:1-7.
33. Komotar RJ, Iorgulescu JB, Raper DM, et al. The role of radiotherapy following gross-total resection of atypical meningiomas: clinical article. J Neurosurg. 2012; 117(4):679-686.
34. Vranic A, Popovic M, Cör A, Prestor B, Pizem J. Mitotic count, brain invasion, and location are independent predictors of recurrence-free survival in primary atypical and malignant meningiomas: A study of 86 patients. Neurosurgery. 2010; 67(4):1124-1132.
35. Durand A, Labrousse F, Jouvet A, et al. WHO grade II and III meningiomas: A study of prognostic factors. J Neurooncol. 2009;95(3):367-375.
36. Hasseleid BF, Meling TR, Rønning P, Scheie D, Helseth E. Surgery for convexity meningioma: Simpson grade I resection as the goal: clinical article. J Neurosurg. 2012;117(6):999-1006.
37. Jääskeläinen J. Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients: A multivariate analysis. Surg Neurol. 1986;26(5):461-469.
38. Jääskeläinen J, Haltia M, Servo A. Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol. 1986;25(3):233-242.
39. Marcus H, Price S, Wilby M, Santarius T, Kirollos R. Radiotherapy as an adjuvant in the management of intracranial meningiomas: Are we practising evidence-based medicine? Br J Neurosurg. 2008;22(4):520-528.
40. Marosi C, Hassler M, Roessler K, et al. Meningioma. Crit Rev Oncol Hematol. 2008;67(2):153-171.
41. Kim JW, Kim DG, Paek SH, et al. Radiosurgery for atypical and anaplastic meningiomas: Histopathological predictors of local tumor control. Stereotactic Funct Neurosurg. 2012;90(5):316-324.
42. Zorludemir S, Scheithauer B, Hirose T, Van Houten C, Miller G, Meyer F. Clear cell meningioma: A clinicopathologic study of a potentially aggressive variant of meningioma. Am J Surg Pathol. 1995;19(5):493-505.
43. Couce M, Aker F, Scheithauer B. Chordoid meningioma: A clinicopathologic study of 42 cases. Am J Surg Pathol. 2000;24(7):899-905.
44. Rogers L, Gilbert M, Vogelbaum MA. Intracranial meningiomas of atypical (WHO grade II) histology. J Neurooncol. 2010;99(3):393-405.